Search for Novo Nordisk AS and
    1. February 2, 2015

      Big pharmaceuticals groups faces biosimilars challenge

      Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

    2. January 25, 2015

      Novo Nordisk to launch weight-loss drug

      Novo Nordisk is preparing a big push behind a new weight-loss treatment that it believes can overcome the reluctance of...

    Special Reports

    1. Combating Diabetes

      Urbanisation, poor diet and failure to exercise have led to record levels of obesity, ...
    Search more Special Reports on this topic.

    1. November 17, 2014

      GlaxoSmithKline leads Access to Medicine Index

      GlaxoSmithKline is leading the pharmaceuticals industry in efforts to widen global access to medicines, according to a...

    2. November 13, 2014

      Spread of city life destroys myth of diabetes as a western illness

      Which country has the most diabetics? The US seems the obvious candidate given its high rate of obesity – the main cause of...

    3. November 13, 2014

      Steps are afoot to supply affordable insulin to the developing world

      The Jutland peninsula in Denmark provides half the world’s supply of insulin, the life-saving pancreatic hormone that...

    4. November 13, 2014

      Diabetes researchers find hope in link with dementia

      From his office at the Hammersmith Hospital in west London, Dr Paul Edison has begun the search for patients to participate...

    5. October 28, 2014

      Sanofi: finding the energy

      Diabetes disrupts the body’s metabolism, sapping it of the energy it needs. Its remedy, insulin, has recently had the same...

    6. September 14, 2014

      Novo Nordisk says US more open to obesity drugs

      US regulators are becoming more open to drugs for tackling obesity, says the chief executive of Novo Nordisk, as the Danish...

    7. May 1, 2014

      Novo Nordisk ends streak of double-digit quarterly growth

      Novo Nordisk failed to post quarterly double-digit sales growth for the first time in 12 years, bringing to an end one of...

    8. April 1, 2014

      Bristol-Myers Squibb: side effects

      One of these things is not like the others, as Big Bird sings. Look at the mega-cap pharma and biotech stocks. In the near...

    9. March 27, 2014

      Baxter: own devices

      Once you’ve played the trump card, what do you do with the rest of your hand? That’s a question Baxter International’s...

    10. March 27, 2014

      Novo Nordisk joins fight against diabetes epidemic in cities

      Novo Nordisk is to team up with some of the world’s biggest cities to find ways of tackling diabetes, amid warnings that the...

    11. January 3, 2014

      Buy China and Scandinavia, sell France and Turkey

      Like almost everyone else, I’m cautiously optimistic about prospects for 2014. I think we’re in the fairly early stages of a...

    12. December 10, 2013

      Novo Nordisk reported to police over disclosure delay on ruling

      Novo Nordisk has been reported to the police by the Danish Financial Supervisory Authority for failing to disclose critical...

    13. November 14, 2013

      Drug manufacturers seek to expand the range of treatments

      Three companies have long dominated the commercial battle over insulin. For nearly a century since it was first developed,...

    14. November 14, 2013

      Diabetes sufferers seek injection of effort

      When Paul Zimmet first conducted research on the island of Nauru nearly four decades ago, he was shocked to find that a...

    15. November 14, 2013

      Universal availability of insulin yet to be achieved

      There are fewer than nine years to go before the centenary of insulin’s introduction in 1922, but David Beran is not ready...

    16. November 7, 2013

      Novo Nordisk faces headwinds to remain biggest Nordic group

      What is the biggest company in the Nordic region? Measured by market capitalisation, it is not AP Møller-Maersk or Ericsson,...

    17. August 22, 2013

      Eli Lilly drawn into pharmaceutical corruption claims in China

      Eli Lilly became the latest western pharmaceutical group to be drawn into escalating allegations of corruption in China,...

    18. August 11, 2013

      Comparing drug prices across borders a difficult task

      Comparing the prices of medicines across borders is an intellectual challenge for academics, a profitable business for...

    19. August 8, 2013

      Novo Nordisk raises forecasts amid demand for diabetes treatments

      Novo Nordisk, the Nordic region’s most valuable company by market capitalisation, raised its sales and profit guidance for...

    20. August 8, 2013

      Chinese drugs industry inquiry widens

      Three more western pharmaceutical companies have been drawn into widening Chinese probes into pricing and marketing...

    21. July 18, 2013

      Belgian pharma group in China probe

      UCB has become the latest focus of inquiries by Chinese officials in a growing clampdown on drug pricing and marketing...

    22. May 1, 2013

      Novo Nordisk/Lundbeck: drugs start working

      The news from Denmark’s sizeable pharmaceuticals sector has been suitably Nordic noir recently. H Lundbeck, beset by patent...

    23. April 15, 2013

      Healthcare bucks sell-off in Europe

      Heathcare was the most sought after sector on Monday amid a wider sell-off on global growth concerns that led to European...

    24. February 15, 2013

      Renault drives on from dire 2012

      Renault convinced investors this week that it had turned a corner after a dire 2012. The French carmaker said it had a net...

    25. February 11, 2013

      Novo Nordisk ails after drug ruling

      News that Novo Nordisk , the Danish drugs company, failed to win approval for a new drug triggered a strong response from...

    26. February 11, 2013

      Novo Nordisk: reality check

      There goes the visibility premium. Novo Nordisk has stood out from rivals in recent years because its growth has been so...

    27. February 11, 2013

      FDA rejects Novo Nordisk insulin remedy

      Novo Nordisk lost DKr80bn from its stock market value after the Danish drugs company failed to win US regulatory approval...

    28. January 8, 2013

      Novo Nordisk rises amid Denmark high

      Denmark’s index of leading blue-chip companies reached an all-time high on Tuesday. Copenhagen’s OMX 20 climbed 0.8 per cent...

    29. December 26, 2012

      Pharma groups hope for diet drugs binge

      As Christmas overeating gives way to under-fulfilled new year diets, the pharmaceutical industry’s appetite has been whetted...

    30. November 18, 2012

      Novo Nordisk becomes largest Nordic group

      Novo Nordisk has become the largest company in the Nordic region by market capitalisation, overtaking Norway’s Statoil,...

    31. November 16, 2012

      SAS survival hangs on crew pay deal

      The future of SAS is hanging in the balance after management issued an ultimatum this week to force pilots and cabin crew to...

    32. November 9, 2012

      Banks drive European equities lower

      Crédit Agricole capped a difficult week for European banks on Friday as the French lender reported a wider than expected net...

    33. October 31, 2012

      Novo Nordisk raises profit guidance

      Novo Nordisk has become one of the rare European companies to raise its profit guidance for the year, as the Danish drugs...

    34. October 4, 2012

      France’s bruiser disrupts Sanofi’s recovery

      The French language does not, I think, contain a verb that means “to mug a well-known company”. How about montebourger?...

    35. July 1, 2012

      BMS / Amylin

      Bad habits equal big opportunities. As the world’s population gets fatter, diabetes is on the rise. The World Health...

    36. March 28, 2012

      Amylin jumps 50% on talk of failed bid

      Shares in Amylin Pharmaceuticals rose more than 50 per cent on Wednesday on reports of a spurned $3.5bn takeover bid for the...

    37. February 5, 2012

      Pharma seeks to ease pain of euro crisis

      With Greece and Spain struggling to repay billions of euros in outstanding debts to the healthcare sector as the eurozone...

    38. January 22, 2012

      Food groups angry at obesity campaign

      Graphic marketing campaigns intended to frighten people about obesity are drawing fire from US beverage and restaurant...

    Search for Novo Nordisk AS and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Rising insulin sales boost growth at Danish pharma group...
      September 14, 2014

      Rising insulin sales boost growth at Danish pharma group

    2. Lex on Novo Nordisk's failure to win approval on insulin drug...
      February 11, 2013

      Lex on Novo Nordisk's failure to win approval on insuli...